As of April 2025 OncoCyte has a market cap of NZ$0.16 Billion. This makes OncoCyte the world's 8980th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | NZ$0.16 B | 161.93% |
2024 | NZ$62.98 M | 92.87% |
2023 | NZ$32.65 M | -45.54% |
2022 | NZ$59.96 M | -79.53% |
2021 | NZ$0.29 B | 31.54% |
2020 | NZ$0.22 B | 16.91% |
2019 | NZ$0.19 B | 127.75% |
2018 | NZ$83.65 M | -59.34% |
2017 | NZ$0.20 B | -29.58% |
2016 | NZ$0.29 B | 26.02% |
2015 | NZ$0.23 B |
On Apr 26th, 2025 the market cap of OncoCyte was reported to be: